Physician profile
Geoffrey Joseph Orme
NPI 1386906881
$26,749.60
in general payments reported to CMS, 2019-2025
15 companies · $3,402 in 2025
The $3,402 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $808 · 2021: $255 · 2022: $2,172 · 2023: $1,787 · 2024: $7,790 · 2025: $3,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,535 · Food and Beverage: $3,044 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,535.21 |
| Food and Beverage | $3,043.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,881.30 | 2019-2025 | Watchman Flx, Empower Leadless Pacemaker System_crm, General - Therapies |
| Medtronic, INC. | $7,010.54 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $4,474.58 | 2019-2025 | Aveir, Gallant, Jot Dx |
| Medtronic Vascular, INC. | $3,066.31 | 2019 | |
| Atricure, INC. | $1,814.23 | 2022-2024 | |
| Philips North America LLC | $1,659.03 | 2024 | (9520) Igt Devices Undivided, (Bs2) Lm Undivided |
| Biosense Webster, INC. | $197.57 | 2021-2025 | Carto 3, Octaray Mapping Catheter |
| Biotronik INC. | $186.09 | 2025 | Acticor 7 Vr-T Dx, Amvia Edge, Solia |
| Cardiva Medical, INC. | $159.20 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.01 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $86.40 | 2023-2024 | Xarelto |
| Siemens Medical Solutions USA, INC. | $34.24 | 2024 | Artis Q Floor |
| Amgen INC. | $26.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.99 | 2025 | |
| Pfizer INC. | $16.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geoffrey Orme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.